Skip to main content
Forums
Log in
Contact us
Policy
The Notify Project
History
Who we are
Interviews
Health authorities
The Experts
Useful links
Global consultation reports
Search Library
Search tutorial
Adverse occurrence search
Reference search
Bibliographic list
Authors
Keywords
Add or update record
Editorial Group Tools
MPHO taxonomy
Adv. occurrence taxonomy
Imputability table
VIDEO TUTORIAL
Database content analysis
Notify Booklet
1 INTRODUCTION
2 THE V&S CHAIN FOR MPHOs
3 VIGILANCE AND SURVEILLANCE: HISTORY AND BASIC ELEMENTS
4 MEDICAL PRODUCTS OF HUMAN ORIGIN (MPHO) - DONATION AND ETHICS
ANNEX 1. Notify Library - MPHO type taxonomy
5 TOWARDS A GLOBAL GOVERNANCE OF MPHO
6 THE V&S SYSTEM IS PRIMARILY A RESPONSIBILITY FOR HEALTH AUTHORITIES
7 ORGANIZATION FOR A COMPREHENSIVE - VIGILANCE & SURVEILLANCE SYSTEM
8 VIGILANCE & SURVEILLANCE - RECOGNITION RELIES ON HEALTH CARE STAFF
9 INVESTIGATING OCCURRENCES THAT COULD CAUSE HARM - LEARNING FROM ERRORS
10 PROJECT NOTIFY
11 THE NOTIFY DATABASE - LEARNING FROM VIGILANCE
12 RISKS ASSOCIATED WITH LIVING DONATION
13 HARM TO RECIPIENT - INFECTIONS
14 HARM TO RECIPIENT - NON INFECTIOUS BLOOD TRANSFUSION REACTIONS
15 HARM TO RECIPIENTS - MALIGNANCY
16 HARM TO RECIPIENTS - GENETIC TRANSMISSIONS - HPC
17 HARM TO RECIPIENTS - GENETIC TRANSMISSIONS - gamets and embryos
18 CHARACTERISTICS, HANDLING AND CLINICAL ERRORS
19 TRACEABILITY, AN ABSOLUTE PRE-REQUISITE FOR MPHO SAFETY
ANNEX 2. Notify Library - Adverse occurrence type taxonomy
REFERENCES
Background Documents
Home
/
ICANS (immune effector cell‐associated neurotoxicity syndrome)
ICANS (immune effector cell‐associated neurotoxicity syndrome)
Chimeric Antigen Receptor Therapy
1972
Read more
about Chimeric Antigen Receptor Therapy
